Zynerba Pharmaceuticals Inc ZYNE:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/28/22 EDT
1.23quote price arrow down-0.01 (-0.81%)
Volume
376,956
52 week range
0.84 - 5.73
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.23
  • 52 Week High5.73
  • 52 Week High Date06/29/21
  • 52 Week Low0.84
  • 52 Week Low Date05/13/22

Key Stats

  • Market Cap53.63M
  • Shares Out43.60M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.99
  • YTD % Change-57.29

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.23
  • 52 Week High5.73
  • 52 Week High Date06/29/21
  • 52 Week Low0.84
  • 52 Week Low Date05/13/22
  • Market Cap53.63M
  • Shares Out43.60M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.99
  • YTD % Change-57.29

RATIOS/PROFITABILITY

  • EPS (TTM)-0.94
  • P/E (TTM)-1.31
  • Fwd P/E (NTM)-1.29
  • EBITDA (TTM)-37.543M
  • ROE (TTM)-47.04%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-34,905.63%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Zynerba Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Zynerba Pharmaceuticals, Inc. is primarily engaged in the pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, including Fragile X syndrome (FXS), autism spectrum disorder (ASD), and 22q11.2 deletion syndrome (22q). Cannabinoids are a class of compounds derived from Cannabis plants. Its two primary cannabinoids contained in cannabis are cannabidiol and tetrahydrocannabinol (THC). The Company is developing Zygel, the...
Armando Anido
Chairman of the Board, Chief Executive Officer
Terri Sebree
President
James Fickenscher CPA
Chief Financial Officer, Vice President - Corporate Development
Address
80 W. Lancaster Avenue, Suite 300
Devon, PA
19333
United States

Top Peers

SYMBOLLASTCHG%CHG
NOVN
Novan Inc
2.30-0.01-0.43%
SCYX
SCYNEXIS Inc
1.89-0.08-4.06%
ACUR
Acura Pharmaceuticals Inc
0.48UNCHUNCH
AVTX
Avalo Therapeutics Inc
0.517-0.003-0.5769%
ACRX
AcelRx Pharmaceuticals Inc
0.2192+0.0112+5.38%